ESOU 2021: Neoadjuvant vs Adjuvant Chemotherapy/Immunotherapy in High-Risk UTUC: Indications and Controversies

(UroToday.com) The second Urothelial Cancer session at this year’s European Association of Urology (EAU) Section of Oncological Urology (ESOU) virtual annual meeting featured a number of presentations, focussing on controversies in the management of urothelial cancers. The first presentation in this session was from Dr. Andrea Necchi who discussed the indications and controversies surrounding the use […]

ESOU 2021: EUO Lecture: Systemic Treatment of Metastatic Renal Cell Carcinoma

(UroToday.com) The EUO lecture at the 2021 European Association of Urology (EAU) Section of Oncological Urology (ESOU) virtual annual meeting was given by Dr. Thomas Powles, a medical oncologist from London discussing the systemic treatment of metastatic renal cell carcinoma. There have been exciting advances in the first-line treatment of metastatic renal cell carcinoma over the last 5-10 […]

ESOU 2021: Clinical Case: PSMA PET, Not Conventional Imaging, Should be Performed for Primary Staging of High-Risk Prostate Cancer

(UroToday.com) The first prostate cancer session at the 2021 European Association of Urology (EAU) Section of Oncological Urology (ESOU) Virtual Annual Meeting featured a number of case presentations focused on diagnosis and staging. The second of these, featuring a case presentation from Dr. Sandro Gaspar and a pro/con debate from Drs. Francesco Ceci and Henk […]

ESOU 2021: Clinical Case: Will Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy Change in the PSMA-PET Era?

(UroToday.com) The second Prostate Cancer session at this year’s European Association of Urology (EAU) Section of Oncological Urology (ESOU) Virtual meeting featured two case presentations (and associated clinical discussions/debates) focused on the management of patients with localized disease. The second of these examined the potentially changing role of pelvic lymph node dissection at the time of […]

ESOU 2021: Reducing Morbidity of Inguinal Lymph Node Staging; New Developments in Inguinal Lymph Node Dissection and Sentinel Node Biopsy

(UroToday.com) The rare tumors session at the European Association of Urology (EAU) Section of Oncological Urology (ESOU) 2021 Virtual meeting included a presentation discussing new developments in inguinal lymph node dissection and sentinel node biopsy, by Dr. Oscar Brouwer from The Netherlands Cancer Institute. Dr. Brouwer notes that penile cancer survival is highly dependent on lymph […]

ESOU 2021: Surgery in Detail – Key Points on Partial Nephrectomy: Preparation of the Renal Hilum – Use of Fluorescence

(UroToday.com) The first Renal Cancer session at this year’s European Association of Urology (EAU) Section of Oncological Urology (ESOU) 2021 Virtual Meeting focused on localized disease and was divided into two primary sections, the first focusing on key points in partial nephrectomy while the second examined approaches to larger renal masses. In the first mini-session examining […]

ESOU 2021: Personalized Therapy to Reduce Treatment Morbidity in Testicular Cancer

(UroToday.com) Renowned testis cancer expert Dr. Peter Albers discussed personalized therapy to reduce treatment morbidity in testicular cancer at the rare tumors session of the European Association of Urology (EAU) Section of Oncological Urology (ESOU) 2021 Virtual meeting. Dr. Albers highlights that testicular cancer survivorship is heterogeneous across Europe ranging from 80% in Eastern Europe to […]

ESOU 2021: Surgery in Detail – Key Points on Partial Nephrectomy: Resection Techniques

(UroToday.com) The first Renal Cancer session at this year’s European Association of Urology (EAU) Section of Oncological Urology (ESOU) 2021 virtual annual meeting focused on localized disease and was divided into two primary sections, the first focusing on key points in partial nephrectomy while the second examined approaches to larger renal masses. In the first mini-session […]

X